Bibliography
List of peer-reviewed papers about or utilizing the LDF DXA Technique
(as of May 2016)
Note: An attempt has been made to present a current and complete list – publications may exist that are not on this list.
Apkon SD, Kecskemethy HH. Bone Health in Children with Cerebral Palsy. J Pediatric Rehabilitation. 2008;1(2):115-21.
Bachrach SJ, Kecskemethy HH, Harcke HT, Lark RK, Miller F, Henderson RC: Pamidronate Treatment and Posttreatment Bone Density in Children with Spastic Quadriplegic Cerebral Palsy. J Clin Densit 2006; 9;2;167-174.
Crabtree NJ, Arabi A, Bachrach LK, Fewtrell M, El-Hajj Fuleihan G, Kecskemethy HH, Jaworski M, Gordon C. Dual-Energy X-ray Absorptiometry Interpretation and Reporting in Children and Adolescents: The Revised 2013 ISCD Official Pediatric Positions. J Clin Densitom. 2014 Apr-Jun;17(2):225-42.
Dominguez-Bartmess SN, Tandberg D, Cheema AM, Szalay EA. Efficacy of alendronate in the treatment of low bone density in the pediatric and young adult population. J Bone Joint Surg Am. 2012 May 16;94(10):e62. Finbråten AK, Syversen U, Skranes J, Andersen GL, Stevenson RD, Vik T Bone mineral density and vitamin D status in ambulatory and non-ambulatory children with cerebral palsy. Osteoporos Int. 2015 Jan;26(1):141-50.
Grissom LE, Kecskemethy HH, Bachrach SJ, McKay CP, Harcke HT. Bone Densitometry in Pediatric Patients Treated with Pamidronate. Ped Radiol; 2005;35:511-517.
Grossberg R, Blackford MG, Kecskemethy HH, Henderson R, Reed MD. Longitudinal assessment of bone growth and development in a facility-based population of young adults with cerebral palsy. Dev Med Child Neurol. 2015 Nov;57(11):1064-9.
Haas RE, Kecskemethy HH, LoPiccolo MA, Hossain J, Dy RT, Bachrach S. Lower Extremity Bone Mineral Density in Children with Congenital Spinal Dysfunction. Dev Med Child Neurol. 2012 Dec; 54(12):1133-1137.
Harcke HT, Kecskemethy HH, Conklin D, Scavina M, Mackenzie WG, McKay CP: Assessment of Bone Mineral Density in Duchenne’s Muscular Dystrophy (DMD) using the Lateral Distal Femur. Journal of Clinical Neuromuscular Disease. 2006 8(1):1-6.
Harcke HT, Stevenson KL, Kecskemethy HH, Bachrach S, Grissom, LE. Fracture after Bisphosphonate Treatment in Children with Cerebral Palsy: The Role of Stress Risers. Ped Radiol. 2012 Jan;42(1):76-81.
Henderson RC, Lark RK, Newman JE, Kecskemethy H. Fung EB, Renner JB, Harcke HT. Normal Pediatric Reference Data for DXA Measures of Bone Density in the Distal Femur. Am. J. Radiol. 2002; 178:439-443.
Henderson RC, Lark RK, Kecskemethy HH, Miller F, Harcke HT, Bachrach SJ. Biphosphonates to Treat Osteopenia in Children with Quadriplegic Cerebral Palsy: A Randomized Placebo-Controlled Clinical Trial. J Peds 2002;141:644-51.
Henderson RC, Kairalla J, Abbas A, Stevenson RD. Predicting low bone density in children and young adults with quadriplegic cerebral palsy. Dev Med Child Neurol. 2004 Jun; 46(6):416-9.
Henderson RC, Kairalla JA, Barrington JW, Abbas A, Stevenson RD. Longitudinal changes in bone density in children and adolescents with moderate to severe cerebral palsy. J Pediatr. 2005 Jun;146(6):769-75.
Henderson RC, Berglund LM, May R, Zemel BS, Grossberg RI, Johnson J, Plotkin H, Stevenson RD, Szalay E, Wong B, Kecskemethy HH, Harcke HT. The Relationship Between Fractures and DXA Measures of BMD in the Distal Femur of Children and Adolescents with Cerebral Palsy or Muscular Dystrophy. J Bone Mineral Res. 2010 Mar; 25(3):520-6.
Henderson RC, Henderson BA, Kecskemethy HH, Hidalgo ST, Nikolova BA, Sheridan K, Harcke HT, Thorpe DE. Adaptation of the Lateral Distal Femur DXA Scan Technique to Adults With Disabilities. J Clin Densitom. 2015 Jan-Mar: 18(1):102-8.
Hobby BD, Dominguez-Bartmess S, Szalay EA. Prevention of postoperative osteopenia using IV pamidronate: a pilot study. J Pediatr Orthop. 2013 Oct-Nov;33(7):763-7.
Houlihan CM, Stevenson RD. Bone density in cerebral palsy. 2009 Aug;20(3):493-508.
Kecskemethy HH, Harcke HT. Assessment of bone health in children with disabilities. J Pediatr Rehabil Med. 2014 Jan 1;7(2):111-24.
Kecskemethy HH, Kubaski F, Harcke HT, Tomatsu S. Bone Mineral Density in MPS IV A (Morquio Syndrome Type A). Mol Genet Metab. 2016 Feb;117(2):144-9.
Khoury DJ, Szalay EA. Bone mineral density correlation with fractures in nonambulatory pediatric patients. J Pediatr Orthop. 2007 Jul-Aug;27(5):562-6.
Mueske NM1, Chan LS2, Wren TA3.Reliability of lateral distal femur dual-energy X-ray absorptiometry measures. J Clin Densitom. 2014 Oct-Dec;17(4):522-7.
Patman LJ, Szalay EA. Relative osteopenia after femoral implant removal in children and adolescents. Orthopedics. 2013 Apr;36(4):e468-72. doi: 10.3928/01477447-20130327-24.
Sees JP, Sitoula P, Dabney K, Holmes L, Rogers K, Kecskemethy HH, Bachrach SJ, Miller F. Pamidronate Treatment to Prevent Reoccurring Fractures in Children with Cerebral Palsy. J Pediatr Orthop. 2016 Mar; 36(2):193-7.
Szalay EA, Harriman D. Adapting pediatric DXA scanning to clinical orthopaedics. J Pediatr Orthop. 2006 Sep-Oct;26(5):686-90.
Szalay EA, Harriman D, Eastlund B, Mercer D. Quantifying postoperative bone loss in children. J Pediatr Orthop. 2008 Apr-May;28(3):320-3.
Szalay EA, Cheema A. Children with spina bifida are at risk for low bone density. Clin Orthop Relat Res. 2011 May;469(5):1253-7.
Tryon E, Szalay EA. The lateral distal femoral DEXA scan in children: a chronology of growing bone? Orthopedics. 2008 Nov;31(11):1093.
Zemel B, Stallings V, Leonard M, Paulhamus D, Kecskemethy HH, Harcke HT, Henderson RC. Revised Pediatric Reference Data for the Lateral Distal Femur Measured by Dual Energy X-Ray Absorptiometry. J Clin Densit 2009; 12:207-218.